Red blood cell transfusion burden by day 30 predicts mortality in adults after single-unit cord blood transplantation

[1]  A. Barrett,et al.  Transfusion support for matched sibling allogeneic hematopoietic stem cell transplantation (1993–2010): factors that predict intensity and time to transfusion independence , 2018, Transfusion.

[2]  Satoshi Takahashi,et al.  Platelet Transfusion Refractoriness in Single-Unit Cord Blood Transplantation for Adults: Risk Factors and Clinical Outcomes. , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  Kirk A Easley,et al.  Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  Satoshi Takahashi,et al.  Cryopreserved CD34+ Cell Dose, but Not Total Nucleated Cell Dose, Influences Hematopoietic Recovery and Extensive Chronic Graft-versus-Host Disease after Single-Unit Cord Blood Transplantation in Adult Patients. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[5]  M. Sanz,et al.  ABO incompatibility does not influence transfusion requirements in patients undergoing single-unit umbilical cord blood transplantation , 2017, Bone Marrow Transplantation.

[6]  D. Allan,et al.  Transfusion of Red Cells in Hematopoietic Stem Cell Transplantation (TRIST Study): A Randomized Controlled Trial Evaluating 2 Red Cell Transfusion Thresholds , 2016 .

[7]  J. Kanda,et al.  Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older , 2016, American journal of hematology.

[8]  J. Kanda,et al.  Comparison of Outcomes of 8/8 and 7/8 Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  Chang Liu,et al.  Red blood cell transfusion for hematologic disorders. , 2015, Hematology. American Society of Hematology. Education Program.

[10]  D. Purtill,et al.  Red cell and platelet transfusion burden following myeloablative allogeneic haemopoietic stem cell transplantation , 2015, Internal medicine journal.

[11]  Satoshi Takahashi,et al.  Single-unit cord blood transplant for acute lymphoblastic leukemia and lymphoma using an intensified conditioning regimen of total body irradiation, high-dose cytarabine and cyclophosphamide , 2015, Leukemia & lymphoma.

[12]  M. Horowitz,et al.  Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. , 2014, Blood.

[13]  K. Uchimaru,et al.  Effect of ABO blood group incompatibility on the outcome of single-unit cord blood transplantation after myeloablative conditioning. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  D. Madtes,et al.  The association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantation , 2014, Transfusion.

[15]  S. Asano,et al.  Single-unit cord blood transplantation after granulocyte colony-stimulating factor-combined myeloablative conditioning for myeloid malignancies not in remission. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[16]  J. Wagner,et al.  Impact of ABO-mismatch on risk of GVHD after umbilical cord blood transplantation , 2013, Bone Marrow Transplantation.

[17]  E. Gehrie,et al.  Clinical guide to ABO-incompatible allogeneic stem cell transplantation. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[18]  O. Hyrien,et al.  Clinical factors affecting engraftment and transfusion needs in SCT: a single-center retrospective analysis , 2013, Bone Marrow Transplantation.

[19]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[20]  D. Allan,et al.  Factors associated with the avoidance of red blood cell transfusion after hematopoietic stem cell transplantation , 2012, Transfusion.

[21]  M. Donato,et al.  Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation , 2011, Bone Marrow Transplantation.

[22]  D. Weisdorf,et al.  Platelet and red blood cell utilization and transfusion independence in umbilical cord blood and allogeneic peripheral blood hematopoietic cell transplants. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[23]  J. Wagner,et al.  Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. , 2010, The Lancet. Oncology.

[24]  M. Sorror,et al.  The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation , 2010, British journal of haematology.

[25]  S. Jhanwar,et al.  Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[26]  S. Asano,et al.  Impact of ABO incompatibility on engraftment and transfusion requirement after unrelated cord blood transplantation: a single institute experience in Japan , 2007, Bone Marrow Transplantation.

[27]  S. Asano,et al.  Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. , 2007, Blood.

[28]  S. Asano,et al.  Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. , 2004, Blood.

[29]  J. Lipton,et al.  RBC transfusion requirements after allogeneic marrow transplantation: impact of the before‐transplant Hb level on transfusion and early survival , 2003, Transfusion.

[30]  R. Storb,et al.  Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings. , 2001, Blood.

[31]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.

[32]  K. Sullivan,et al.  Chronic graft-versus-host disease and other late complications of bone marrow transplantation. , 1991, Seminars in hematology.